These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8886293)

  • 21. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow.
    Mathew RJ; Wilson WH
    Psychiatry Res; 1991 Oct; 40(2):125-34. PubMed ID: 1684872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic effects on serine and glycine metabolism.
    Baruah S; Waziri R; Sherman A
    Biol Psychiatry; 1993 Oct; 34(8):544-50. PubMed ID: 7903868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
    Vallabhajosula S; Hirschowitz J; Machac J
    J Nucl Med; 1997 Feb; 38(2):203-7. PubMed ID: 9025736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspects of stability of regional cerebral blood flow in chronic schizophrenia: an 18-year followup study.
    Cantor-Graae E; Warkentin S; Franzén G; Risberg J; Ingvar DH
    Psychiatry Res; 1991 Dec; 40(4):253-66. PubMed ID: 1811243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
    Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
    Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients.
    Gonul AS; Kula M; Sofuoglu S; Tutus A; Esel E
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):29-33. PubMed ID: 12664310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Meibach RC
    Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
    [No Abstract]   [Full Text] [Related]  

  • 30. The characteristics of side-effects of bromperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Ishida M; Tanaka O; Mihara K; Kaneko S; Otani K
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):103-6. PubMed ID: 11929578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment.
    Galderisi S; Mucci A; Mignone ML; Maj M; Kemali D
    Schizophr Res; 1991 Dec; 6(1):15-23. PubMed ID: 1786232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdomyolysis and acute renal failure during high-dose haloperidol therapy.
    Marsh SJ; Dolson GM
    Ren Fail; 1995 Jul; 17(4):475-8. PubMed ID: 7569118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics.
    Kim CE; Kang DY; Ha KS; Jeong SH; Kim YS
    Biol Psychiatry; 1995 Dec; 38(12):843-5. PubMed ID: 8750045
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
    Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW
    J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.
    Hwang TJ; Lin SK; Lin HN
    J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M; Winter C; Kagerer S; Brunnauer M; Laux G; Möller HJ
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
    Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
    J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.